Gynecological cancer (uterine cancer, ovarian cancer/fallopian tube cancer)
Conditions
Interventions
None listed
Sponsors
Kitano Hiromi
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: - Agreed web questionnaire survey. - 18 year and older. - Live in Japan. - Received chemotherapy for uterine cancer, ovarian cancer, or fallopian tube cancer. - Agreed web questionnaire survey. - Doctors, nurses, or pharmacists who are engaged in drug treatment for gynecological cancer.
Exclusion criteria
Exclusion criteria: - Have families engaged in pharmatheutical/survey/marketing company or health care. - Have double cancer. - Doctors with less than 5 years of experience as a doctor (including training period). - Nurses and pharmacists with less than 1 year of experience.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Current status of SDM (Desirability and reality of reflecting patients' own values in their decision making) - Differences in what patients and health care professionals consider important when choosing drug treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Preference for multidisciplinary intervention in decision-making by patients and health care professionals, and the type of work desired. - Background factors associated with decision-making type - Identification of the most distressing side effects experienced by the patient | — |
Contacts
Public ContactAmi Kato
Eisai Co., Ltd.
Outcome results
None listed